Full title: HTL0039732 in Participants With Advanced Solid Tumours
Age: 18+
Locations:
Cambridge – Addenbrooke’s Hospital
Brief summary:
The purpose of this trial is to evaluate a new drug, HTL0039732, that will be administered on its own (as a monotherapy) and in combination with atezolizumab or with other approved anti-cancer therapies, in participants with advanced solid tumours.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.
